Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions|
|Abstract:||Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.|
|Inventor(s):||Lin; Henry C. (Manhattan Beach, CA), Pimentel; Mark (Los Angeles, CA)|
|Assignee:||Cedars-Sinai Medical Center (Los Angeles, CA)|
|Filing Date:||Apr 17, 2001|
|Claims:||1. A method of treating irritable bowel syndrome in a human subject comprising: detecting the presence of small intestinal bacterial overgrowth in the subject; and at least partially eradicating the small intestinal bacterial overgrowth by depriving the bacterial overgrowth of nutrients by causing the subject to consume a diet comprising VIVONEX.RTM.. |
2. The method of claim 1, wherein the VIVONEX.RTM. is consumed for at least 3 days.
3. The method of claim 1, wherein the VIVONEX.RTM. is consumed for 10 to 14 days.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.